These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 4638610

  • 1. [Clinical study on 20 gastroduodenal ulcer patients treated with 2-p-methyl sulphonylphenyl imidazol (1,2-alpha) pyridine (zolimidine)].
    García Alvarez M, Ramírez Armengol JA.
    Rev Clin Esp; 1972 Aug 31; 126(4):353-6. PubMed ID: 4638610
    [No Abstract] [Full Text] [Related]

  • 2. [Clinical evaluation of a new synthetic preparation (zolimidine) in the treatment of gastroduodenal diseases].
    Rivero Fontán JL, Barranco Jiménez M, Gómez Parra M.
    Rev Esp Enferm Apar Dig; 1972 Jul 31; 38(1):103-26. PubMed ID: 5069487
    [No Abstract] [Full Text] [Related]

  • 3. [Use of a new drug in the treatment of gastroduodenal diseases].
    Bagliani A, Borri P.
    Minerva Gastroenterol; 1972 Jul 31; 18(3):165-74. PubMed ID: 4614114
    [No Abstract] [Full Text] [Related]

  • 4. Metabolic fate of Zolimidine. II. Analytical profile, tissue levels and urinary excretion in animals and in man.
    Picco S, Bonaldi A, Frigerio A, Danieli B, Almirante L.
    Farmaco Sci; 1974 Nov 31; 29(11):848-60. PubMed ID: 4442573
    [No Abstract] [Full Text] [Related]

  • 5. [Effect, on gastric absorption, of a new molecule with mucopoietic activity, 2-)p-methylsulfonylphenyl)-imidazo (1,2-a) pyridine, used in therapy of gastroduodenal diseases].
    Barlattani M.
    Clin Ter; 1971 Dec 15; 59(5):417-30. PubMed ID: 5159600
    [No Abstract] [Full Text] [Related]

  • 6. Study of the concentration of mucoprotein in the gastric juice from healthy subjects and gastroduodenal patients before and after treatment with a gastro-protective drug, zolimidine.
    Camarri E, Zaccherotti L, D'Alonzo D.
    Arzneimittelforschung; 1972 Apr 15; 22(4):768-72. PubMed ID: 5068258
    [No Abstract] [Full Text] [Related]

  • 7. Metabolic fate of Zolimidine. I. Studies in rats with the 14-C-labelled molecule.
    Almirante L, Picco S, Bonaldi A, Cattaneo R.
    Farmaco Sci; 1974 Nov 15; 29(11):841-7. PubMed ID: 4442572
    [No Abstract] [Full Text] [Related]

  • 8. Metabolic fate of zolimidine. III. Chemical structure of the principal metabolites in human urine.
    Almirante L, Danieli B, Frigerio A, Mugnaini A, Picco S.
    Farmaco Sci; 1974 Dec 15; 29(12):941-56. PubMed ID: 4442583
    [No Abstract] [Full Text] [Related]

  • 9. [Controlled clinical evaluation of the therapeutic activity of 3 antiulcer agents in peptic ulcer: carbenoxolone, proglumide and zolimidine].
    Fossati C.
    Clin Ter; 1979 Mar 31; 88(6):605-19. PubMed ID: 157245
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Anti-secretory therapy of peptic ulcer with cimetidine and activation of the mucosal barrier with zolimidine: preliminary results of combined treatment].
    Assisi R, De Miranda B, De Stefano S.
    Clin Ter; 1980 Jun 15; 93(5):563-75. PubMed ID: 6448726
    [No Abstract] [Full Text] [Related]

  • 13. [Behavior of blood values of prolactin, TSH, FSH, and LH in gastroduodenal ulcer during drug therapy].
    Melloni R, Melloni GF, Scarazatti E.
    Boll Soc Ital Biol Sper; 1984 Apr 30; 60(4):761-7. PubMed ID: 6234007
    [Abstract] [Full Text] [Related]

  • 14. Tenatoprazole. Benatoprazole, TU 199.
    Drugs R D; 2002 Apr 30; 3(4):276-7. PubMed ID: 12455204
    [No Abstract] [Full Text] [Related]

  • 15. [Blood levels and urinary excretion of zolimidine-indomethacin combination].
    Saggioro A, Picco S, Catto E.
    Boll Chim Farm; 1974 Feb 30; 113(2):98-105. PubMed ID: 4848149
    [No Abstract] [Full Text] [Related]

  • 16. The effect of zolimidine, imidazopyridine-derivate, on the duodenal ulcer healing.
    Belohlavek D, Malfertheiner P.
    Scand J Gastroenterol Suppl; 1979 Feb 30; 54():44. PubMed ID: 161649
    [Abstract] [Full Text] [Related]

  • 17. Influence of 'cytoprotective' drugs (carbenoxolone, zolimidine, prostanoic acid) on mucus secretion in patients with gastric ulcer.
    Parodi MC, Molinari F, Barocci S.
    Scand J Gastroenterol Suppl; 1984 Feb 30; 92():163-6. PubMed ID: 6234649
    [Abstract] [Full Text] [Related]

  • 18. [Trial treatment of gastroduodenal ulcers with pyridine-2-aldoxime methyl methanesulfonate (RP 7676), a cholinesterase reactivator].
    CELICE J, AUBERT P, DUCHESNAY G, ROUSSELET J.
    Therapie; 1960 Feb 30; 15():1264-77. PubMed ID: 13691873
    [No Abstract] [Full Text] [Related]

  • 19. [Newly developed H2-receptor antagonists in the treatment of peptic ulcer disease].
    Simon B, Müller P, Dammann HG.
    Wien Med Wochenschr; 1982 May 31; 132(10):223-8. PubMed ID: 6126962
    [Abstract] [Full Text] [Related]

  • 20. [Synthesis of gastric juice and ulcer-inhibiting compounds with a new mechanism of action].
    Farkas L, Fuchs O, Andrási F.
    Acta Pharm Hung; 1973 Jul 31; 43(3):111-5. PubMed ID: 4747706
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.